“The Preceptorship” is an interactive learning model developed by Professor Eva Segelov covering landmark clinical trials in specific cancers, with mentorship from experts in the field. It has been applied in the areas of lung and colorectal and GU cancers to aid trainees and junior consultants in understanding of the evolution of management and evidence behind contemporary clinical practice.
The 1 ½ day workshop covers landmark clinical trials in kidney, bladder and testicular cancers or prostate cancer. Target participants are trainees and junior consultants in medical, radiation, surgical oncology, palliative care, nuclear medicine and relevant non-oncology specialty eg urology.
The 2020 GU Preceptorship is still to be announced.
Overview of ANZUP GU Preceptorship in Prostate Cancer 2019
Date: 29 - 30 November 2019
Location: Intercontinental Sydney Double Bay
Convenor: Prof Eva Segelov, supported by Dr Cameron McLaren and Dr Alison Zhang
Preceptors: A/Prof Louise Emmett, Dr Amy Hayden, A/Prof Jarad Martin, Dr Cameron McLaren, Dr Shahneen Sandhu, A/Prof Jeremy Shapiro and Prof Henry Woo
The 1 ½ day workshop will cover landmark clinical trials in prostate cancer. Our target participants are trainees and junior specialists in urology, radiation oncology, medical oncology, nuclear medicine and imaging.
Areas covered included multimodality management of early, locally advanced and metastatic disease and supportive care. Click here for more information.
Involvement in a Preceptorship is a significant commitment involving 6-8 hours of preparation prior to attending the meeting. Participants need to apply online stating why they would like to do the course and which papers they would like to present. Places are limited and expected to fill quickly. The first fully completed applications will be the first to be confirmed. Successful applicants will be supported to attend this exciting initiative. Registration for all attendees is a fully non-refundable fee of $250.
If you are not already a member of ANZUP, please submit a membership application form which is a condition of attendance. Membership is free and you can apply online. Members receive regular updates on research activities and access to the website members' area. If you have any questions or need to identify a proposer feel free to contact us.
If you require further information please contact us at email@example.com.
Professor Eva Segelov
Discipline: Medical Oncology
Eva Segelov is Professor and Director of Oncology at Monash University and Monash Health, Melbourne. She has specialist interest in the diagnosis and management of upper and lower gastrointestinal cancers, including neuroendocrine tumours. Prof Segelov has led multiple national and international oncology clinical trials and has published over 100 articles, expert reviews and book chapters. She is a frequent invited speaker at national and international conferences and has convened the COSA and AGITG Annual Scientific Meetings. In 2015 she co-founded the international research collaborative the Commonwealth Neuroendocrine Tumour Society (CommNETS). In 2016 she was nominated as a European Society of Medical Oncology (ESMO) Faculty member for the CUP, Endocrine Tumours and Others group; in 2018 she was appointed as ESMO Faculty member for Gastrointestinal Cancer. Professor Segelov is Associate Editor for the ASCO publication of Journal of Global Oncology (ASCO) and the online video journal JoVE. Professor Segelov heads a translational cancer laboratory at Monash University. Having been awarded the Vice Chancellors medal for teaching excellence at UNSW and following attendance at the Harvard-Macy short course for Medical Education, Eva developed the unique “Seminal Advances Preceptorship” educational model, that has run now over more than 5 years, in multiple tumour streams.
2019 GU Preceptorship in Prostate Cancer supported by: